XRCC1 and urothelial carcinoma: At the same time, the “risky” ERCC6 1097Val allele increased the frequency of urothelial carcinoma recurrences [69] and the XRCC1 399 A/A (Gln/Gln) genotype greatly reduced recurrence free survival of BCG treated patients [70].